๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

172 ORAL ANTIVIRAL THERAPY WITHOUT LONG TERM MAINTENANCE HEPATITIS B IMMUNOGLOBULIN TO PREVENT HEPATITIS B RECURRENCE IN LIVER TRANSPLANT PATIENTS

โœ Scribed by J. Ahn; S.F. Dodson; S.M. Cohen

Book ID
117376098
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
70 KB
Volume
48
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Low risk of hepatitis B virus recurrence
Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy
โœ Stephen N. Wong; Chi-Jen Chu; Chun-Tao Wai; Terese Howell; Charles Moore; Robert ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

Hepatitis B virus (HBV) recurrence rates of 0-16% had been reported in patients maintained on nucleoside analogues (NA) after hepatitis B immunoglobulin (HBIG) discontinuation after orthotopic liver transplantation (OLT). However, follow-up in most studies was short. We aimed to determine the long-t